Search Results - "Seehofer, D."

Biliary Complications After Liver Transplantation: Old Problems and New Challenges by Seehofer, D., Eurich, D., Veltzke‐Schlieker, W., Neuhaus, P.

“…Due to a vulnerable blood supply of the bile ducts, biliary complications are a major source of morbidity after liver transplantation (LT). Manifestation is…”
Get full text

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3 by Modest, D.P., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C.J., Gebauer, B., Modest, H.I., Held, S., Folprecht, G., Heinemann, V., Neumann, U.P.

“…The FIRE-3 trial investigated combination chemotherapy plus either cetuximab or bevacizumab in patients with untreated metastatic colorectal cancer (mCRC) not…”
Get full text

Once‐Daily Prolonged‐Release Tacrolimus (ADVAGRAF) Versus Twice‐Daily Tacrolimus (PROGRAF) in Liver Transplantation by Trunečka, P., Boillot, O., Seehofer, D., Pinna, A. D., Fischer, L., Ericzon, B.‐G., Troisi, R. I., Baccarani, U., Ortiz de Urbina, J., Wall, W.

“…The efficacy and safety of dual‐therapy regimens of twice‐daily tacrolimus (BID; Prograf) and once‐daily tacrolimus (QD; Advagraf) administered with steroids,…”
Get full text

Twenty‐Year Longitudinal Follow‐Up After Orthotopic Liver Transplantation: A Single‐Center Experience of 313 Consecutive Cases by Schoening, W. N., Buescher, N., Rademacher, S., Andreou, A., Kuehn, S., Neuhaus, R., Guckelberger, O., Puhl, G., Seehofer, D., Neuhaus, P.

“…With excellent short‐term survival in liver transplantation (LT), we now focus on long‐term outcome and report the first European single‐center 20‐year…”
Get full text

Cardiovascular outcomes after simultaneous pancreas kidney transplantation compared to kidney transplantation alone: a propensity score matching analysis by Lange, U G, Rademacher, S, Zirnstein, B, Sucher, R, Semmling, K, Bobbert, P, Lederer, A A, Buchloh, D, Seidemann, L, Seehofer, D, Jahn, N, Hau, H-M

“…Coronary heart disease due to arteriosclerosis is the leading cause of death in type 1 diabetic patients with end-stage renal disease (ESRD). The aim of this…”
Get full text

Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation by Kamphues, Carsten, Seehofer, D., Eisele, R. M., Denecke, T., Pratschke, J., Neumann, U. P., Neuhaus, P.

“…Background Intrahepatic cholangiocarcinoma (IHC) is a rare liver malignancy with a rising incidence worldwide. Since no standard treatment has been established…”
Get full text

Treatment, outcome and quality of life after Fournier's gangrene: a multicentre study by Czymek, R., Kujath, P., Bruch, H.-P., Pfeiffer, D., Nebrig, M., Seehofer, D., Guckelberger, O.

“…Aim The object of this study was to describe the course of Fournier's gangrene and assess quality of life in a group of affected patients. Method We evaluated…”
Get full text

Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation by R. Veelken, S. Ebel, A. Schindler, F. Lordick, M.F. Struck, C. Girbardt, F. Ziemssen, D. Seehofer, T. Denecke, T. Berg, F. van Bömmel

“…Background: Hepatic chemosaturation by isolated percutaneous liver perfusion (CS-PHP) with melphalan controls hepatic tumor growth. However, optimal treatment…”
Get full text

Factors influencing conversion to resectability and survival after resection of metastases in RAS WT metastatic colorectal cancer (mCRC): A FIRE-3 analysis by Modest, D P, Heinemann, V, Folprecht, G, Denecke, T, Pratschke, J, Lang, H, Bemelmans, M, Becker, T, Rentsch, M, Seehofer, D, Bruns, C, Gebauer, B, Held, S, Neumann, U, Ricard, I

Get full text

Intraoperative Placement of External Biliary Drains for Prevention and Treatment of Bile Leaks After Extended Liver Resection Without Bilioenteric Anastomosis by Strücker, B., Stockmann, M., Denecke, T., Neuhaus, P., Seehofer, D.

“…Background Improved surgical techniques, substantial preoperative diagnostics, and advanced perioperative management permit extensive and complex liver…”
Get full text

T-drain reduces the incidence of biliary leakage after liver resection by Eurich, Dennis, Henze, S., Boas-Knoop, S., Pratschke, J., Seehofer, D.

“…Biliary leakage is a serious complication after liver resection and represents the major cause of post-operative morbidity. In spite of already identified risk…”
Get full text

Significant impact of patient age on outcome after liver resection for HCC in cirrhosis by Faber, W, Stockmann, M, Schirmer, C, Möllerarnd, A, Denecke, T, Bahra, M, Klein, F, Schott, E, Neuhaus, P, Seehofer, D

“…Abstract Objective Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The majority of patients with HCC have cirrhosis…”
Get full text

Evaluation for surgical treatment options in metastatic colorectal cancer (mCRC) – a retrospective, central evaluation of FIRE-3 by Neumann, U., Denecke, T., Pratschke, J., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C.J., Gebauer, B., Folprecht, G., Stintzing, S., Held, S., Heinemann, V., Modest, D.P.

Get full text

Effect of pre- and probiotics on liver regeneration after resection: a randomised, double-blind pilot study by Rayes, N, Pilarski, T, Stockmann, M, Bengmark, S, Neuhaus, P, Seehofer, D

“…Liver regeneration is a prerequisite for extended liver surgery. Several studies have shown that the bacterial gut flora is able to modulate liver function…”
Get more information

Hepatic Arterial Infusion with Oxaliplatin and 5-FU/Folinic Acid for Advanced Biliary Tract Cancer: A Phase II Study by Sinn, M., Nicolaou, A., Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H., Hildebrandt, B.

“…Background Effective and tolerable chemotherapy with gemcitabine and cisplatin for advanced biliary tract cancer (BTC) has been established recently. However,…”
Get full text

Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop® compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619) by Moench, C., Mihaljevic, A. L., Hermanutz, V., Thasler, W. E., Suna, K., Diener, M. K., Seehofer, D., Mischinger, H. J., Jansen-Winkeln, B., Knaebel, H. P., Bechstein, W. O.

“…Background Despite improvements in liver surgery over the past decades, hemostasis during hepatic resections remains challenging. This multicenter randomized…”
Get full text

Reducing mortality in liver surgery by introduction of the dynamic liver function test LiMAx by Stockmann, M, Bednarsch, J, Jara, M, Malinowski, M, Gebhardt, S, Seehofer, D, Pratschke, J

Get full text

Functional considerations regarding the allps procedure – Can we still reliably predict postoperative liver function? by Bednarsch, J, Bluethner, E, Malinowski, M, Pratschke, J, Seehofer, D, Stockmann, M

Get full text

Current status of multimodal therapy for colorectal liver metastases by Seehofer, D, Neuhaus, P

“…Surgical resection is the only chance of cure for patients with colorectal liver metastases und significantly improves patient survival. The percentage of…”
Get more information

Donor Age Does Not Influence 12-Month Outcome After Orthotopic Liver Transplantation by Faber, W, Seehofer, D, Puhl, G, Guckelberger, O, Bertram, C, Neuhaus, P, Bahra, M

“…Abstract Objective Orthotopic liver transplantation (OLT) is the most effective treatment for patients with end-stage liver disease to date. The discrepancy…”
Get full text